Search Results
You are looking at 1 - 1 of 1 items for
- Author: Z. POLISHUK x
- Refine by access: All content x
Y. PFEIFER
Y. PFEIFER
Search for other papers by Y. PFEIFER in
Google Scholar
PubMed
Search for other papers by Y. PFEIFER in
Google Scholar
PubMed
E. SADOVSKY
E. SADOVSKY
Search for other papers by E. SADOVSKY in
Google Scholar
PubMed
Search for other papers by E. SADOVSKY in
Google Scholar
PubMed
Z. POLISHUK
Z. POLISHUK
Search for other papers by Z. POLISHUK in
Google Scholar
PubMed
Search for other papers by Z. POLISHUK in
Google Scholar
PubMed
F. G. SULMAN
F. G. SULMAN
Search for other papers by F. G. SULMAN in
Google Scholar
PubMed
Search for other papers by F. G. SULMAN in
Google Scholar
PubMed
SUMMARY
Subcutaneous injection of the 5-hydroxytryptamine (5-HT) antagonist cyproheptadine hydrochloride (Periactin) produced a significant decrease in uptake of [14C]5-HT (serotonin) in the myometrium and to a lesser degree in the ovaries, foetuses and heart of pregnant rats. This effect of cyproheptadine was considerably increased in rats pretreated with the monoamine oxidase inhibitor pargyline hydrochloride. These results suggest that the anti-abortive effect of cyproheptadine is based on specific inhibition of the contractile effect of 5-HT on the myometrium. The hypothesis is advanced that cyproheptadine competes with serotonin for its receptors and thus blocks the effect of serotonin.
